AEVI GENOMIC MEDICINE INC's ticker is GNMX and the CUSIP is 00835P105. A total of 29 filers reported holding AEVI GENOMIC MEDICINE INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $5,329,000 | -2.7% | 36,500 | 0.0% | 1.64% | +6.3% |
| Q3 2019 | $5,475,000 | +54650.0% | 36,500 | -43.3% | 1.54% | +51300.0% |
| Q2 2019 | $10,000 | -100.0% | 64,390 | +105.1% | 0.00% | -100.0% |
| Q4 2018 | $38,610,000 | 0.0% | 31,390 | 0.0% | 12.28% | +4.5% |
| Q3 2018 | $38,610,000 | +91828.6% | 31,390 | 0.0% | 11.75% | +73356.2% |
| Q2 2017 | $42,000 | – | 31,390 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|